NORML

APRIL 30, 2020

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” ” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. percent in 2016).”

Chronic Pain 348

Chronic Pain Clinical Trials Data Patients 348

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.

CBD 306

CBD Clinical Trials Data Treatment 306

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry. .

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 21, 2021

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

Cannabis Life Network

JULY 5, 2022

Every year sees a pile of scientific research supporting the use of cannabis as a treatment for cancer. Clinical evidence, however, has yet prove that cannabinoids, terpenes, or cannabis treat cancer. 1, 2) Before legalization in […]. 1, 2) Before legalization in […].

Clinical Trials 86

Clinical Trials Patients Terpenes Treatment 86

FloridaMarijuana.net

AUGUST 15, 2018

Treatment usually aims at reducing reactions and to diminishing the acuity of the reactions. Treatments also seek to increase the subject’s ability to manage trauma-related emotions and to greater confidence in coping abilities. The post Medical Marijuana Offers Hope for Treatment of PTSD appeared first on.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 212

Clinical Trials Chronic Pain Data Treatment 212

The Fresh Toast

JULY 22, 2020

Marijuana Shows Promise In Sickle Cell Disease Treatment. Clinical trial results indicate cannabis could provide an alternative or adjunctive treatment to sickle cell patients. The post Marijuana Shows Promise In Sickle Cell Disease Treatment appeared first on The Fresh Toast.

Treatment 105

Treatment Clinical Trials Marijuana Patients 105

LifeCannMD

JULY 3, 2024

#image_title Medical Marijuana is becoming a widely used treatment for anxiety and mood disorders like PTSD (Post-Traumatic Stress Disorder). Fear Extinction: THC has been shown to facilitate the extinction of fear memories, a crucial process for PTSD treatment. Sleep Improvement: Many PTSD sufferers experience insomnia and nightmares.

Treatment 96

Treatment Clinical Trials Marijuana Sleep 96

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

AUGUST 24, 2021

Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19. TORONTO–(BUSINESS WIRE)–FSD Pharma Inc.

Clinical Trials 81

Clinical Trials Treatment Pharmaceutical Concentrates 81

Veriheal

JULY 18, 2023

Recognizing that the efficacy of treatment relies not only on the therapeutic substances themselves but also on the skill and knowledge of the individuals administering them, this bill explicitly supports the training of practitioners. This could foster a pool of experts well-versed in applying psychedelic-assisted therapy.

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98

Cannabis Law Report

JULY 19, 2021

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In part of one of this series, we analyzed the discussions surrounding using cannabis for mental health. In part two, we took a deep look at using cannabis for depression. In part three, we will analyze the available research concerning cannabis and anxiety. Can you use cannabis for anxiety? Cannabis and Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

FloridaMarijuana.net

AUGUST 16, 2018

The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

MMJ Recs

NOVEMBER 30, 2023

While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. In recent years, there has been growing interest in exploring alternative treatment options, and one that has gained attention is medical marijuana (MMJ).

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Veriheal

AUGUST 28, 2023

And it further reinforces the need to carry out clinical trials to determine the safety and efficiency of using psilocybin to treat OCD. This treatment is believed to have long-lasting effects that can positively improve the quality of life and mental well-being of such individuals.

Treatment 78

Treatment Clinical Trials Therapy Research and Development 78

Veriheal

SEPTEMBER 18, 2020

Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury.

Treatment 98

Treatment Chronic Pain CBD Research and Development 98

Cannabis Law Report

FEBRUARY 27, 2022

“Securing Clinical Trial Authorisation solidifies over 16 months of hard work and dedication from our team and positions Halucenex as one of very few Canadian companies with approval to commence a clinical trial utilising psychedelic substances on mental health conditions,” president, CEO and founder Bill Fleming said.

Clinical Trials 52

Clinical Trials Data Treatment Conditions 52

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Project CBD

FEBRUARY 27, 2023

In the absence of an answer — or a cure — treatment is the name of the game for fibromyalgia. But there’s another option that can address mood, pain, and more at once, all with fewer side effects: cannabis. It’s not a new idea.

THC 144

THC CBD Clinical Trials Sleep 144

Cannabis Law Report

AUGUST 23, 2021

Phase I clinical trial of the Satipharm CBD capsules in which results demonstrated the safety and high performance of the oral capsule technology, including the superior delivery profile of cannabidiol (CBD) compound to trial subjects. The treatment was generally well tolerated and the median reduction in seizures was 81.9%

Clinical Trials 105

Clinical Trials CBD Epilepsy Treatment 105

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. ” Dr. Gallow prides himself on his work as a South African cannabis advocate and leader in the international medical cannabis research field. About the Opioid Epidemic.

Clinical Trials 116

Clinical Trials Chronic Pain Hydroponic Strains 116

Cannabis Law Report

AUGUST 15, 2021

Creso Pharma’s (CPH) subsidiary, Halucenex, is being awarded a dealer’s licence in Canada, allowing it to advance its clinical trial plans. Halucenex says the licence allows it to progress its planned phase two clinical trial of psilocybin on treatment-resistant post-traumatic stress disorder.

Clinical Trials 105

Clinical Trials Treatment Business 105

Cannabis Law Report

JANUARY 11, 2023

PRESS RELEASE UK company Chanelle McCoy Health granted Ethics Approval to commence Phase III Efficacy Clinical Trial for the treatment of Sleep Disturbance CMH-CBD-001 using their Ultra Pure Synthetic Cannabinoid (CBD) formulation with pharmaceutical grade FDA registered raw material.

Clinical Trials 52

Clinical Trials CBD Sleep Pharmaceutical 52

MMJ Recs

JULY 30, 2024

This has spurred interest in alternative treatments like treating PTSD with cannabis, which interacts with the body’s endocannabinoid system, implicated in stress regulation and emotional processing. Looking ahead, the future of medical cannabis in PTSD treatment hinges on overcoming these challenges.

Therapy 116

Therapy Treatment Clinical Trials Sleep 116

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. None of it was initially slated to go to clinical trials. The deadline for proposals is Friday, July 16. Read more at.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

Cannabis Law Report

AUGUST 22, 2021

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. The company believes that the same homing peptide approach could improve the safety and efficacy of psychedelic treatments. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. Virtual Clinical Trials transcend geographic, mobility and economic barriers. Authored By : Arundati Dandapani.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

The Cannigma

OCTOBER 11, 2021

Published in Cannabis and Cannabinoid Research in late September, the survey found that the majority of respondents reported that their health conditions were “very much improved” or “much improved” by the use of CBG. No clinical trial was used in the compilation of the study. who have used it to treat anxiety.

Conditions 132

Conditions Clinical Trials Chronic Pain Cannabinoids 132

The Cannigma

MARCH 18, 2021

The majority of people with Parkinson’s disease in the United States have not used cannabis to treat their symptoms due to a lack of scientific evidence about its effectiveness. Of those who have used cannabis, most did not receive a recommendation from a doctor or instructions on how to use it, according to the findings of a recent study.

Patients 141

Patients Clinical Trials Treatment Cannabis 141

The Cannigma

MAY 19, 2021

Medical : Illegal Recreational : Illegal *CBD products are legal in Japan, as long as they contain no THC whatsoever and are not made from cannabis flower. Japan is known for its world-leading innovations, technology, and design, but when it comes to cannabis, the island nation remains decidedly regressive. But in modern times?

Law 140

Law Legalization Clinical Trials CBD 140

Cannabis Law Report

SEPTEMBER 2, 2021

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Cannabinoids 105

Cannabis Law Report

DECEMBER 9, 2021

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. DENVER, Dec.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Canna Law Blog

JANUARY 22, 2020

The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Psilocybin!

Clinical Trials 140

Clinical Trials Decriminalization Microdosing Food 140

CannaMD

JUNE 2, 2021

However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms. In addition, cannabis users participating in the survey were younger by an average of 3 years in age than non-users in the survey. Why Do Parkinson’s Patients Use Marijuana?

Patients 105

Patients Clinical Trials Treatment Research and Development 105